Sacha Satram, PhD

Vir Biotechnology

Disclosure(s): Vir Biotechnology: Employee, Vir Biotechnology Vir shareholder

Poster(s):

• 1145 - Real-world Effectiveness of Sotrovimab for the Early Treatment of COVID-19 in the US
  Friday, October 21, 2022

  12:15 PM – 1:30 PM US ET